Patent & Trade Mark
Attorneys
We are
Experts in Navigating IP in the Asia Pacific Region
Thanks to many years of global experience, FB Rice has a network of trusted advisors in all key jurisdictions. We turn to those advisors when assisting our clients to promote their interests.

For specific information on our Asia Pacific capability, click here.

 

 
One door to South East Asia
For a seamless service for filing and prosecuting patent and trade mark applications in South East Asia, click here.

 

Rachel Hooke

Partner

Rachel Hooke
“The importance of innovation in the medical technology is growing and FB Rice is here to help our clients protect their investment in research.”
“The importance of innovation in the medical technology is growing and FB Rice is here to help our clients protect their investment in research.”
Inventorship – a muddy concept at best
Inventorship has been described as “one of muddiest concepts in the muddy metaphysics of the patent law.” Mueller Brass Co. v. Reading Industries, Inc., 352 F.Supp. 1357, 1372 (E.D.Pa. 1972). Determining inventorship is a complex issue that is undertaken on a much stricter basis than authorship of a scientific publication. It can also be a particularly contentious issue when people are not named as inventors. Not only can this lead to alienation, but it can also lead to legal issues. For example, a patent may be invalid if incorrect inventors are intentionally named. During litigation, a defendant may also be able to identify an unnamed inventor and obtain an assignment from them, thereby qualifying as a co-owner of the patent and no longer subject to the litigation.
Inventorship has been described as “one of muddiest concepts in the muddy metaphysics of the patent law.” Mueller Brass Co. v. Reading Industries, Inc., 352 F.Supp. 1357, 1372 (E.D.Pa. 1972). Determining inventorship is a complex issue that is undertaken on a much stricter basis than authorship of a scientific publication. It can also be a particularly contentious issue when people are not named as inventors. Not only can this lead to alienation, but it can also lead to legal issues. For example, a patent may be invalid if incorrect inventors are intentionally named. During litigation, a defendant may also be able to identify an unnamed inventor and obtain an assignment from them, thereby qualifying as a co-owner of the patent and no longer subject to the litigation.
07 March 2017
Victorian Government opens new fund to fast-track medical research
The inaugural round of the Victorian Medical Research Acceleration Fund aims to support the translation of early stage health and medical research into better health outcomes for patients, whilst also boosting the economy with job creation and further investment into Victoria’s medical research sector.
The inaugural round of the Victorian Medical Research Acceleration Fund aims to support the translation of early stage health and medical research into better health outcomes for patients, whilst also boosting the economy with job creation and further investment into Victoria’s medical research sector.
Kate Mahady

Director

Kate Mahady

Kate is the Director of FB Rice R&D Tax Consulting. She has over fourteen years’ experience in Research & Development Tax incentive consulting in 'Big 4' accounting firms with strong experience in advising a broad range of technology based companies from start ups to large multinationals. Kate is dedicated to assisting Australian companies navigate the complex R&D tax landscape to provide maximised, supportable claims to enable them to fund further research and development projects.

Kate is the Director of FB Rice R&D Tax Consulting. She has over fourteen years’ experience in Research & Development Tax incentive consulting in 'Big 4' accounting firms with strong experience in advising a broad range of technology based companies from start ups to large multinationals. Kate is dedicated to assisting Australian companies navigate the complex R&D tax landscape to provide maximised, supportable claims to enable them to fund further research and development projects.

29 March 2017
Kate Mahady | 2017 Global Business Camps
Kate Mahady, Director R&D Tax Consulting, is looking forward to attending the 2017 Global Business Camp conference on the Gold Coast next week.
Kate Mahady, Director R&D Tax Consulting, is looking forward to attending the 2017 Global Business Camp conference on the Gold Coast next week.
Interfering RNA (iRNA) is no interference to manner of manufacture in Australia
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.